DILMORE JILLIAN enters BAUDAX BIO, INC. with 263.00 shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 4/26/2022ACC: 0001062993-22-010762
OfficerOther· Corporate Controller/Secretary
Since Apr 2022
263.00
Baseline shares
100% direct
263.00
Direct ownership
3 positions
732.00
Derivative underlying
3 instruments
3
Security positions
All direct
Non-Derivative Holdings3
Common Stock
DirectShares owned25.00
Common Stock
DirectShares owned171.00
Common Stock
DirectShares owned67.00
Total
263.00 direct263.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 25.00 | Direct |
| Common Stock | 171.00 | Direct |
| Common Stock | 67.00 | Direct |
| Total | 263.00 | 263.00 direct |
Derivative Holdings3
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
313.00
Shares owned
N/A
Exercise price
45.50
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
162.00
Shares owned
N/A
Exercise price
39.20
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
257.00
Shares owned
N/A
Exercise price
221.55
Expiration
—
Exercise window
—
Total
Underlying
732.00
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 45.50 | — | — | 313.00 | N/A |
| Stock Option (right to buy) Direct | Common Stock | 39.20 | — | — | 162.00 | N/A |
| Stock Option (right to buy) Direct | Common Stock | 221.55 | — | — | 257.00 | N/A |
| Total | 732.00 | 0.00 | ||||